Speakers

Yeşim

Aktas

Erciyes University, Faculty of Pharmacy, Department of Pharmaceutical Technology

Turkey

Rita

Ambrus

University of Szeged

 

Hungary

Ildikó

Bácskay

University of Debrecen

 

Hungary

Annette

Bauer-Brandl

University of Southern Denmark

Denmark

Zerrin Sezgin

Bayindir

Ankara University, Faculty of Pharmacy, Department of Pharmaceutical Technology

Turkey

Rok

Frlan

University of Ljubljana, Faculty of Pharmacy

Slovenia

Mirjana

Gašperlin

University of Ljubljana, Faculty of Pharmacy

Slovenia

Andrea

Heinz

University of Copenhagen, LEO Foundation Center for Cutaneous Drug Delivery, Department of Pharmacy

Denmark

Tuba

İnceçayir

Gazi University

 

Turkey

Anssi-Pekka

Karttunen

University of Helsinki

 

Finland

Mirjam Gosenca

Matjaž

University of Ljubljana, Faculty of Pharmacy

Slovenia

Piotr

Merks

Cardinal Stefan Wyszyński University in Warsaw

Poland

Aleš

Obreza

University of Ljubljana, Faculty of Pharmacy

Slovenia

Leena

Peltonen

University of Helsinki

 

Finland

Jarkko

Rautio

School of Pharmacy, University of Eastern Finland

Finland

Mia

Sivén

University of Helsinki

 

Finland

Éva

Szökő

Semmelweis University

 

Hungary

Astrid

Subrizi

School of Pharmacy, University of Eastern Finland

Finland

Tamás

Tábi

Semmelweis University

 

Hungary

Tambet

Teesalu

University of Tartu

 

Estonia

Yalçın

Özkan

University of Health Sciences; Gülhane Faculty of Pharmacy

Turkey

Dr. Rita Ambrus, is an Associate Professor in Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged. Professor Ambrus is also an experimental leader of Nanotechnological Research group of Interdisciplinary Excellence Centre University of Szeged. Her research interest is development of technological procedures (nano- and microparticle production) and alternative drug administration (pulmonary and intranasal) to reach improved bioavailability of poorly water-soluble drugs. She published more than 180 research articles (IF: around 550; Q1/D1 type of publication: 130; first or corresponding author by 70 publications) with almost 2000 independent citations and her H index is 31. 

 She has active cooperation with national and international (8 active cooperation in Europe) higher education institutions and pharmaceutical industry partners. She is active member of the Spanish PhD Program Academic Commission (PPAC) in "Drug Research and Development" of the University of Santiago de Compostela and also a leading researcher of the Bulgarian "Strategic research and innovation program "Biomaterials and Nanostructure Drug Delivery" working group. She was a PI by Serbian, Slovenian and Croatian bilateral projects. She coordinated and managed the scientific work of 18 PhD students and 3 postdoctoral fellows. 

 

 

Annette Bauer-Brandl is an accredited pharmacist from Germany with a doctoral degree in Pharmaceutics (Dr.rer.nat.) on physical processes during tableting.

After holding several research positions in Wellcome (London, UK), Novartis (Basle CH), and at the University of Freiburg, Germany, she was appointed professor at University of Tromsø, Norway. There she was involved in starting the cand. pharm. curriculum; her current position in Odense also embraced the start-up of the cand. pharm. curriculum.

She is well-known for her awarded Handbook on Formulation, Manufacturing and Quality Assurance of Solid Dosage Forms (“Die Tablette”, 4th ed. 2023). She serves at the EDQM (European Directorate for Quality of Medicines) in the Expert Group 12 (Dosage Forms and Methods).

Her research background is on the solid state of drug substances, the dissolution process and solvation of drug molecules. Currently her research interest focusses on prediction of oral bioavailability of drugs from formulations, especially for enabling formulations of poorly soluble drugs. Examples of study are enabling formulations such as amorphous solid dispersion (ASDs) based on polymers and surfactants, as well as cyclodextrin formulations and co-crystals. Her group has invented the artificial biomimetic membrane Permeapad® that allows permeation experiments under harsh conditions such as digestive processes. Alternative novel devices and set-ups to study dissolution / permeation simultaneously in more detail (e.g. Permealoop ™) or using high throughput formats (96 well plates) are being developed. Novel analytical tools to measure free drug concentrations are being also used and evaluated. These efforts are directed towards 3R: animal-free drug development by improved IVIVCs.

 

 

Associate Professor Mia Sivén's research focuses on sustainable dosage forms and manufacturing, regulatory science, and educational research. Her doctoral thesis in biopharmacy focused on the development of gastro-retentive dosage forms to enhance bioavailability, utilising a novel pharmaceutical excipient of nature origin. Throughout her career, she has pursued her passion for pharmaceutical dosage forms and processes, addressing the unmet needs of specific patient groups. She has supervised several theses in this area, the most recent of which focused on 3D printed age-appropriate dosage forms for pediatric patients. She has a broad methodological experience in pharmaceutical research, encompassing laboratory work and qualitative and quantitative research methods. Secondments to a pharmaceutical company in Ireland have deepened her understanding of industry operations and regulations. She has also been merited as an educator and developer of higher education, having been awarded the esteemed Fellowship of the Teachers’ Academy. In 2020, she was granted the Title of Docent in Industrial Pharmacy. Currently, she serves as Vice-Dean of the Faculty of Pharmacy at the University of Helsinki. In 2024, she was appointed to the newly established Professorship of Sustainable Pharmacy. She emphasises the importance of a comprehensive approach to sustainable pharmacy, encompassing sustainability perspectives throughout the life cycle of medicines, and the significance of transdisciplinary collaboration